SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,209,959 | -74.9% | 58,793 | -42.7% | 0.00% | -75.0% |
| Q2 2023 | $4,826,273 | +21.8% | 102,643 | +8.7% | 0.01% | +14.3% |
| Q1 2023 | $3,962,828 | +18.6% | 94,443 | +7.8% | 0.01% | +16.7% |
| Q4 2022 | $3,339,996 | -12.5% | 87,572 | -10.2% | 0.01% | -14.3% |
| Q3 2022 | $3,819,000 | +61.6% | 97,533 | +33.3% | 0.01% | +75.0% |
| Q2 2022 | $2,363,000 | -4.1% | 73,166 | -1.7% | 0.00% | +33.3% |
| Q1 2022 | $2,463,000 | -24.1% | 74,426 | -2.4% | 0.00% | -25.0% |
| Q4 2021 | $3,243,000 | – | 76,237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |